Trials / Completed
CompletedNCT01436487
Study to Examine the Effects of MultiStem in Ischemic Stroke
Double-Blind, Randomized, Placebo-Controlled Phase 2 Safety and Efficacy Trial of MultiStem® in Adults With Ischemic Stroke
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 134 (actual)
- Sponsor
- Healios K.K. · Industry
- Sex
- All
- Age
- 18 Years – 83 Years
- Healthy volunteers
- Not accepted
Summary
A study to examine the safety and potential effectiveness of the adult stem cell investigational product, MultiStem, in adults who have suffered an ischemic stroke. The hypothesis is that MultiStem will be safe and provide benefit following an ischemic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | MultiStem | single infusion 1-2 days following ischemic stroke |
| BIOLOGICAL | Placebo | single infusion 1-2 days following ischemic stroke |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2015-03-01
- Completion
- 2015-12-01
- First posted
- 2011-09-19
- Last updated
- 2016-08-02
Locations
32 sites across 2 countries: United States, United Kingdom
Source: ClinicalTrials.gov record NCT01436487. Inclusion in this directory is not an endorsement.